AstraZeneca Pharma P/B Ratio
AstraZeneca Pharma (ASTRAZEN) P/B ratio is 19.22 (High), book value per share ₹1746.00 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore ASTRAZEN fundamental worth to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ASTRAZEN P/B Ratio — Valuation Insights & Book Value Analysis
AstraZeneca Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 19.22 (High). For live price, earnings yield and the full fundamental profile, see AstraZeneca Pharma share price today.
- Stock appears overvalued with PB of 19.22, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 321.9% above historical average
- Trading at premium to sector average PB of -0.01
AstraZeneca Pharma P/B Ratio Historical Trend
ASTRAZEN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read ASTRAZEN dividend growth for the complete payout history and dividend yield track record.
ASTRAZEN Historical P/B Ratio — Book Value Per Share & Year-End Price
AstraZeneca Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 3.87 | ₹1746.0 | ₹6751.50 | ₹873 | High |
| 2025 | 5.86 | ₹1540.0 | ₹9029.00 | ₹770 | High |
| 2024 | 5.13 | ₹1424.0 | ₹7305.15 | ₹712 | High |
| 2023 | 4.69 | ₹1178.0 | ₹5526.60 | ₹589 | High |
| 2022 | 3.23 | ₹1022.0 | ₹3297.15 | ₹511 | High |
ASTRAZEN vs Healthcare Peers — P/B Ratio Comparison
AstraZeneca Pharma P/B 19.22 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |